- Home
- CLNN vs ACHL Comparison
CLNN vs ACHL Comparison
Compare CLNN & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- ACHL
- Stock Information
- Founded
- CLNN 2012
- ACHL 2016
- Country
- CLNN United States
- ACHL United Kingdom
- Employees
- CLNN N/A
- ACHL N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLNN Health Care
- ACHL Health Care
- Exchange
- CLNN Nasdaq
- ACHL Nasdaq
- Market Cap
- CLNN 43.0M
- ACHL 40.4M
- IPO Year
- CLNN N/A
- ACHL 2021
- Fundamental
- Price
- CLNN $4.17
- ACHL $1.06
- Analyst Decision
- CLNN Strong Buy
- ACHL Hold
- Analyst Count
- CLNN 4
- ACHL 3
- Target Price
- CLNN $55.25
- ACHL $2.83
- AVG Volume (30 Days)
- CLNN 64.6K
- ACHL 163.2K
- Earning Date
- CLNN 11-13-2024
- ACHL 11-14-2024
- Dividend Yield
- CLNN N/A
- ACHL N/A
- EPS Growth
- CLNN N/A
- ACHL N/A
- EPS
- CLNN N/A
- ACHL N/A
- Revenue
- CLNN $421,000.00
- ACHL N/A
- Revenue This Year
- CLNN N/A
- ACHL N/A
- Revenue Next Year
- CLNN $1,058.37
- ACHL N/A
- P/E Ratio
- CLNN N/A
- ACHL N/A
- Revenue Growth
- CLNN N/A
- ACHL N/A
- 52 Week Low
- CLNN $3.82
- ACHL $0.63
- 52 Week High
- CLNN $12.00
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- CLNN 34.75
- ACHL 60.69
- Support Level
- CLNN $3.88
- ACHL $1.01
- Resistance Level
- CLNN $4.78
- ACHL $1.08
- Average True Range (ATR)
- CLNN 0.49
- ACHL 0.04
- MACD
- CLNN -0.16
- ACHL -0.00
- Stochastic Oscillator
- CLNN 13.43
- ACHL 53.85
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.